
Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial
Fox News
Pfizer said it has selected lower dosages of its COVID-19 vaccine for Phase 2/3 portions of its clinical trial involving kids younger than 11 than the volume given to shot recipients ages 12 and older.
A spokesperson told Fox News in a statement that the lower dosages were determined "based on the safety, tolerability and immunogenicity from our Phase 1 study."More Related News

Students return to Brown University amid questions over security policies that enabled mass shooting
Brown University shooting survivors return to campus as students voice safety concerns following deadly attack by Claudio Manuel Neves-Valente that killed two students.












